Andreas Michael Schmitt

15PUBLICATIONS
149CO-AUTHORS
Language documentation and descriptionApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Economic models and forecastingMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 10, 2026
Data Extraction From Oncology Imaging Reports by Large Language Models: A Comparative Accuracy Study.

|Jul 10, 2026
10-Years of First-Line Ipilimumab and Nivolumab in Advanced Melanoma: A Single Centre Experience.

|Jul 11, 2025
Reply to: On meta-analytic models and the effect of hydroxychloroquine use in COVID-19.

Andreas M Schmitt, Cathrine Axfors, David Moher

|Feb 25, 2025
Author Correction: Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours.

Ignacio Melero, Maria de Miguel Luken, Guillermo de Velasco

|Dec 11, 2024
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours.

Ignacio Melero, Maria de Miguel Luken, Guillermo de Velasco

|Oct 07, 2024
Dual Immune Checkpoint Inhibition in Melanoma and PD-L1 Expression: The Jury Is Still Out.

Andreas Michael Schmitt, James Larkin, Sapna P Patel

Pageof 3

Frequent Collaborators

4 joint publications

Lars G Hemkens

4 joint publications

John P A Ioannidis

4 joint publications

David Moher

3 joint publications

Sherief Abd-Elsalam